We develop injectable controlled release formulations with a strong focus on stability, usability, and controlled delivery. Our capabilities include: • Long-acting injectables (LAI) for sustained therapeutic effect • Low-volume SC/IM formulations suitable for patient-friendly administration • Stability optimization for sensitive APIs, biologics, and nanoparticles • Targeted drug delivery using nano- and micro-structured carriers • Inorganic nanoparticle carriers for specialized therapeutic applications These parenteral solutions are optimized for sterile manufacturing, high API loading, and precise particle-size control.
